Paid

A low-calorie diet was a safe and effective treatment for individuals with newly diagnosed T2D and obesity.

In managing type 1 diabetes, a single combined formulation of pramlintide and prandial insulin can provide multiple benefits.

CREDENCE trial shows that canagliflozin, an SGLT2 inhibitor, lowers the risk of cardiovascular and renal events in patients with T2DM, regardless of prior history of heart failure. 

Systemic review shows sex, age, comorbid conditions, insulin use, and several out-of-range lab predictors on hospital admission, all play a role in COVID-19 severity.

Dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1RAs create an additive effect for increased anti-inflammation and vascular protection.

Stroke has been linked to diabetes, but can analysis of fasting glucose provide greater insight into who is most at risk?

A recent study looked at how different diets can affect blood glucose levels in patients with type 1 diabetes.

Every comorbidity related to diabetes causes life expectancy to plummet and medical costs to soar.

The most common treatment for T2D has been the metformin-sulfonylurea combo; how do SGLT-2 inhibitors compare in all-cause mortality risk?

Cardiovascular and renal disease burdens also occur in type 1 diabetes.